...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Notice anything different about #11

I see zenith is not exactly in a hurry to rush out the meeting results. 

Share
New Message
Please login to post a reply